Login / Signup

Different treatment response to systemic corticosteroids according to white blood cell counts in severe COVID-19 patients.

Kwang Yong ChoiDong Hyun KimKwang Nam JinHyo Jin LeeTae Yun ParkBorim RyuJung-Kyu LeeEun Young HeoDeog Kyeom KimHyun Woo Lee
Published in: Annals of medicine (2022)
Leukopoenia may be related with a better response to systemic corticosteroid therapy in COVID-19 patients requiring oxygen supplementation.KEY MESSAGESIn severe COVID-19 treated with systemic corticosteroids, patients with leukopoenia showed a lower hazard for composite poor outcome compared to patients with normal white blood cell counts or leukocytosis.Leukopoenia may be a potential biomarker for better response to systemic corticosteroid therapy in COVID-19 pneumonia.
Keyphrases
  • sars cov
  • coronavirus disease
  • cell therapy
  • single cell
  • drug induced
  • early onset
  • bone marrow
  • mechanical ventilation